Weaver Consulting Group Neogenomics Inc Transaction History

Weaver Consulting Group

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 29, 2021	SELL	$36.08 - $56.47 $10,824 - $16,941	-300 Closed	0 $0
Q2 2020 Jul 24, 2020	BUY	$24.21 - $31.02 $7,263 - $9,306	300 New	300 $9,000
Q1 2020 Apr 28, 2020	SELL	$20.5 - $34.53 $20,500 - $34,530	-1,000 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$18.96 - $29.84 $18,960 - $29,840	1,000 New	1,000 $19,000

295

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.06B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Weaver Consulting Group, based on Form 13F filings with the SEC.

Stay updated on Weaver Consulting Group with notifications on news.